← Back to Search

Health services research (PC TEACH) for Human Papillomavirus

N/A
Recruiting
Led By Elisa Rodriguez
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
PARENT/GUARDIAN SURVEY: English speaking
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years (60 months)
Awards & highlights

Study Summary

This trial focuses on improving HPV vaccination rates in rural areas by implementing evidence-based strategies in primary care settings. The goal is to increase awareness and access to the HPV vaccine in these communities to prevent cancer effectively

Who is the study for?
This trial is for primary care settings in rural areas that are looking to improve their rates of HPV vaccination. The focus is on implementing a program called PC TEACH, which aims to educate and facilitate better vaccination practices.Check my eligibility
What is being tested?
The study tests the effectiveness of an educational intervention known as PC TEACH designed to optimize HPV vaccine delivery in rural primary care. It evaluates how well this strategy works in increasing vaccination rates against human papillomavirus.See study design
What are the potential side effects?
Since this trial involves an educational intervention rather than a medical treatment, there are no direct side effects associated with medications or vaccines. Indirect effects may include changes in clinic operations or patient-provider interactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a parent or guardian who speaks English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years (60 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years (60 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Adolescent HPV vaccination rates
Secondary outcome measures
Age at vaccination

Trial Design

1Treatment groups
Experimental Treatment
Group I: Health services research (PC TEACH)Experimental Treatment1 Intervention
Primary practice providers sites receive PC TEACH over 3.5 hours for 12 months

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,343 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,669 Previous Clinical Trials
40,926,305 Total Patients Enrolled
Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
30,791 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for patients to participate in this medical study?

"As per the details on clinicaltrials.gov, this investigation is currently in search of eligible candidates. The trial was first made public on May 24th, 2023, with the most recent update dated February 5th, 2024."

Answered by AI

What is the current number of participants eligible for enrollment in this clinical research study?

"Indeed, data from clinicaltrials.gov highlights that this investigation is actively seeking subjects. The trial was initially posted on May 24th, 2023 and last modified on February 5th, 2024. It aims to enroll a total of 16 patients at a single site."

Answered by AI
~11 spots leftby Apr 2027